Profil
Dr. Magali Taiel, MD, is a Chief Medical Officer at Gensight Biologics SA. Dr. Taiel was previously employed as a Vice President-Clinical Development by ProQR Therapeutics NV and a Project Manager by Servier SAS. She received her doctorate degree from Universite Paris Cite.
Aktive Positionen von Magali Taiel
| Unternehmen | Position | Beginn |
|---|---|---|
| GENSIGHT BIOLOGICS S.A. | Technik-/Wissenschafts-/F&E-Leiter | 08.10.2019 |
Ehemalige bekannte Positionen von Magali Taiel
| Unternehmen | Position | Ende |
|---|---|---|
| PROQR THERAPEUTICS N.V. | Corporate Officer/Principal | 01.09.2018 |
Servier SAS
Servier SAS Pharmaceuticals: MajorHealth Technology Operates as a pharmaceutical company | Corporate Officer/Principal | 01.01.2001 |
Ausbildung von Magali Taiel
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 4 |
|---|---|
Gensight Biologics SA
Gensight Biologics SA Pharmaceuticals: MajorHealth Technology Manufactures and markets novel therapies for severe retinal neurodegenerative diseases | Health Technology |
ProQR Therapeutics NV
ProQR Therapeutics NV Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company with interest in the discovery and development of therapeutics for the treatment of genetic disorders | Health Technology |
Universite Paris Cite
Universite Paris Cite Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Servier SAS
Servier SAS Pharmaceuticals: MajorHealth Technology Operates as a pharmaceutical company | Health Technology |
















